市場調査レポート

世界の医薬品・バイオテクノロジー業界の有望企業:新たな標的などの発見に伴う、疾患治療のための革新的療法の精力的な追及

Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets.

発行 MP Advisors 商品コード 295954
出版日 ページ情報 英文 72 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
世界の医薬品・バイオテクノロジー業界の有望企業:新たな標的などの発見に伴う、疾患治療のための革新的療法の精力的な追及 Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets.
出版日: 2015年01月21日 ページ情報: 英文 72 Pages
概要

新たな標的やアプローチ、バイオ医薬品が発見されるたびに、世界各国の製薬企業がそれらに基づく新たな疾患治療薬法の開発を精力的に進めています。特に注目を集めているのが幹細胞治療や再生医療です。ただし、余りにも多くの企業が参入していて補足が難しく、また再生医療の分野も深く広いため、当レポートでは近年特に注目すべき成果を挙げた企業に焦点を当てて、その成果と将来性について考察します。

当レポートでは、世界の医薬品・バイオテクノロジー分野における薬物療法の革新と改善に貢献すると期待される有望な小規模の研究専門企業を取り上げ、各企業の主な促進因子、競合情勢、その他のパイプライン薬、市場機会および主要マイルストーンなどを調査しております。

パート1:再生医療・幹細胞ベース細胞療法の有望企業と、未来の医薬品

  • CESCA Therapeutics Inc.:幹細胞ベース装置・治療法のリスクへの対処と、海外への進出
  • Ocata Therapeutics Inc:眼病への注力 - 黄斑再生の条件 - 「新しい眼」への注目
  • Orgenesis:糖尿病への注力 - 肝臓が再びインスリンを生産できるようになる!
  • Tigenix NV:脂肪組織の活用 - 脂肪の使い道が拓ける?
  • Pluristem Therapeutics Inc:再生医療と再利用 - 胎盤を用いた自己移植治療
  • Mesoblast:韓国の再生医療のリーダー - 国際市場への注力
  • Medipost Co Ltd:韓国の再生医療のリーダー - 国際市場への注力
  • JCRファーマ:日本初の移植片対宿主病 (GVHD) 向け幹細胞ベース製品
  • ジャパン・ティッシュ・エンジニアリング:再生医療への自信 - 富士フイルムの写真から再生医療への転換

パート2:インドの革新的企業 - 将来有望な企業

  • Connexios:可視性を高めるための、パイプライン製品の成熟化と糖尿病/メタボリック症候群への注力
  • Cellworks:In silico技術プラットフォームの普及見通し - 個別化医療・がんへの注力
  • Bugworks:重篤な院内感染へのIn silico技術プラットフォームの提供 - 今すぐ必要な技術
  • Tergene:低価格の第二世代ワクチン - 新興国市場の緊急ニーズへの対応

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 4477

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space.

The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year.

Key Criteria for Our Selection are:-

  • Uniqueness of the Technology platform and the ability to scale up commercially in case of positive outcome of products in the pipeline
  • Pipeline and clinical data analysis
  • Marketed product and commercial tie up. Robustness of the Management, financial and business model.

Part 1- Rising Stars in Regenerative Medicine and Stem cell based Cell Therapies-Drugs of the Future

Company Analysis:

CESCA Therapeutics Inc.: Hedging the Risk with Stem Cell Based Devices and Therapies and Global Presence

  • Figure 1: Products In Pipeline
  • Table 1: Clinical Development- Critical Limb Ischemia (ClI)Data Key Milestones

Ocata Therapeutics Inc: Ophthalmic Focus- Macular degenerative conditions- Looking with a New Eye

  • Figure 1: Market For Age-Related Macular Degeneration (AMD)
  • Figure 2: Products In The Pipeline

Orgenesis: Focus- Diabetes- Tricking your Liver to Make Insulin!

  • Technology Platform
  • Figure 1: Schematic Representation Of Making Autologous Insulin Producing (AIP) Cell

Tigenix NV: Exploiting the Adipose Tissue- Multiple Applications of Fat?

  • Technology Platform
  • Marketed Products
  • Figure 1: Products In Pipeline
  • Key Milestones

Pluristem Therapeutics Inc: Regenerating and Recycling- Allogenic Therapies from the Placenta

  • PluriX 3D Technology Platform
  • Pipeline
  • Figure 1: Classification Of Peripheral Arterial Disease Types
  • Market Opportunity
  • Key Milestones

Mesoblast: Leader in Regenerative Sapce in Korea- Focusing on International Markets

  • Technology Platform
  • Pipeline- Focus on four major areas
  • Figure 1: Drugs In The Pipeline
  • Figure 2: CHFf Discease Classification And Target Patients In PhIII Trial
  • Figure 3: PhiII Data Of MPC-150 In CHF
  • Figure 4: Market Opportunity In Chronic Low Back Pain (CLBP)
  • Key Milestones

Medipost Co Ltd: Leader in Regenerative Space in Korea- Focusing on International Markets

  • Marketed and Products in the Pipeline
  • Key Milestones
  • Figure 1: Sales By Business Segment

JCR Pharmaceuticals co. Ltd.: First Stem Cell Based Product in Japan for Graft-Versus-Host Disease (GVHD).

  • Technology Platform
  • Product in the Pipeline
  • Key Milestones
  • Facts and Financials
  • Table 1: Pipeline Table
  • Figure 1: Sales By Business Segments

Japan Tissue Engineering co. Ltd: Building Confidence in Regenerative Medicine- Fuji film Venture from Colors to Regenerative Medicine-

  • Plat form Focus
  • Products
  • Figure 1: Therapy and Product Focus

Part II-Indian Innovators- Rising Stars:

Table 1: Select new generation innovation /drug discovery Indian companies

Connexios: Maturing Pipeline and Focus on Diabetes/Metabolic Disorders to Drive Visibility

  • Technology Platform
  • Therapy Focus-Diabetes/Metabolic Disorder and Non Alcoholic Steatohepatitis (NASH)
  • Key Milestones
  • Table 1: Differences Between G-Protein Coupled Receptor Agonists
  • Table 2: Pipeline Of GPR Agonist For Treatment Of Type 2 Diabetes
  • Figure 1: Products In Pipeline- Diabetes
  • Figure 2: Products In Pipeline For NASH
  • Figure 3: Other Programs

Cellworks: In silico Technology Platform Poised to Deliver- Focus on Personalised Medicine and Cancer

  • Figure 1: Simulation Based Personalized Medicine
  • Figure 2: Cellworks Therapeutic Programs

Bugworks: In silico Technology platform being applied to Serious Hospital Infections- Need of the hour!

  • Therapy focus- Serious Hospital Infection
  • Technology Platform
  • Figure 1: Drug Development Success For TB
  • Figure 2: Going Way Froward

Tergene: Affordable and Second Generation Vaccines- Addressing the Urgent needs of Emerging Markets.

  • Development Strategy and Status
  • Figure 1: Sales Of Currently Available Vaccines For Streptococcus Pneumonia
  • Figure 2: WW Demand Forecast Of Vaccines For Streptococcus Pneumonia
  • Figure 3: Vaccine Market
Back to Top